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Kimura disease (KD) is a chronic inﬂammatory disorder with angiolymphatic proliferation, usually aﬀecting young men of Asian
race but is rare in other races. The etiology of KD is still unknown. It is often accompanied by nephrotic syndrome. Herein, we
present an atypical manifestation of Kimura disease occurring in a Caucasian man with steroid-responsive early membranous
glomerulonephritis. Kimura disease can present atypically in a middle-aged Caucasian man with secondary steroid-responsive
nephrotic syndrome. Steroid, endoxan, and MMF can be used safely and successfully in such situation. The diagnosis of KD can
be diﬃcult and misleading, and patients with this disease are often evaluated using avoidable procedures by just not being aware
of KD.
1.Introduction
Kimura disease (KD) is a chronic inﬂammatory disorder
with angiolymphatic proliferation, usually aﬀecting young
men of Asian race but is rare in western countries [1]. It
is often accompanied by nephrotic syndrome and is a rare,
chronic inﬂammatory disorder of unknown cause [2].
Chen et al. [3] reported 21 histopathology specimens
conducted in the United States by the US Armed Forces
Institute of Pathology and concluded that, though rare, if
clinicallysuspected,KDshouldbeincludedinthediﬀerential
diagnosis for people of any racial group. KD is usually seen
in young adults, with most patients being aged between 20
and 40 years of age; men are aﬀected more commonly than
women, with a 3:1 ratio [4].
The etiology of KD is still unknown but may be due to
impairment or interference with immune regulation, atopic
reactiontoapersistentantigenicstimulusbyarthropodbites,
virus, and neoplasm. The most interesting hypothesis sug-
gests Candida acting as a source of persistent antigenaemia,
although neither hyphae nor spores have been isolated. The
disease is manifested by hyperplasia of lymphoid follicles
and vascular endothelium. Peripheral eosinophilia and the
presenceofeosinophilsintheinﬂammatoryinﬁltratesuggest
that KD might be a kind of hypersensitivity reaction.
With lymphocyte, T-helper 2 (Th2) might play a role
[4].
Patients with KD may present with a solitary enlarged
painless lymph node or generalized lymphadenopathy (67%
to 100%) [2]. It classically presents as a nontender subcuta-
neous swelling in head and neck region, predominantly in
preauricular and submandibular area. It may be associated
with lymphadenopathy (both local and distal), marked
peripheral eosinophilia, and an elevated IgE level [5].
Coexisting renal disease is common, with an incidence
ranging from 10% to 60% [6], while 10% to 12% of patients
may suﬀer from nephrotic syndrome [6]c h a r a c t e r i z e db y
clinically relevant proteinuria in 12% to 16% of cases [7].
Renal impairment is probably due to immunocomplex-
mediated damage or to Th2-dominant immune response
disorders.
Herein, we present an atypical manifestation of Kimura
disease occurring in a Caucasian man with steroid-respon-
sive early membranous glomerulonephritis.2 International Journal of Nephrology
Figure 1: Irregular and thick basement membrane (H&E) and
vaculizations of basement membrane of glomerulus (silver stain).
2.Case
Fifty-year-old male Egyptian engineer who was suﬀering
from hypertension since 10 years has recently presented to
our outpatient clinic—in Mansoura Urology and Nephrol-
ogy Center—with generalized anasarca, renal impairment
after 18 months of the appearance of multiple small non-
tender masses at his forehead, temporal region, and behind
the left ear. He gave no past history of chronic diarrhea
suggesting inﬂammatory bowel disease.
On clinical examination, he was moderately obese
(BMI: 35), and his blood pressure was controlled on his
previousmedications.Clinicalexaminationrevealedbilateral
basal crepitations and moderate edema of both lower limbs.
His laboratory assessment showed that his renal func-
tion was impaired (creatinine, 2.4mg/dL), normal elec-
trolytes, low serum albumin (0.9mg/dL), high cholesterol
(280mg/dL), proteinuria (8.9grams/day). His hemoglobin
was normal and also the total white cell count but his
diﬀerential count showed eosinophilia (20%).
The virology proﬁle was negative regarding hepatitis
B and C, cytomegalovirus, and HIV. The immunological
status revealed negative Antidouble strands DNA and both
anticytoplasmic neutrophilic antibodies (ANCA-P and C).
However, erythrocyte sedimentation rate was markedly
elevated, tumor markers were normal (prostatic-speciﬁc
antigen, carcinoembryonic antigens, and alpha fetoprotein),
and IgE level was elevated.
Renal ultrasound evaluation revealed average sized kid-
neyswithgradeIechogenicityoftherightkidneybutnormal
left kidney.
CT chest and MRI excluded evidence of underlying
malignancy or lymphadenopathy. Therefore, ultrasound
guided renal biopsy was carried out and light micro-
scopic examination showed only 4glomeruli/section. All of
them were slightly enlarged but normocellular with occa-
sional capillary loops showing small epithelial projections
on silver methenamine stain, in addition to eosinophilic
interstitial inﬁltrates (Figures 1 and 2), hence the diag-
nosis of early membranous nephropathy. Unfortunately
   
Figure 2: Eosinophilic interstitial inﬁltrates in renal tissue.
 
Figure 3: Eosinophilic inﬁltrates of skin lesion.
immunoﬂuorescence and electron microscopy could not
be performed and the patient refused rebiopsy. Excisional
biopsy from the skin lesions at the temporal region
was revised and revealed eosinophilic interstitial inﬁltrates
(Figure 3) with blood vessels in lymphoid follicles (angi-
olymphoid hyperplasia).
So the two biopsy ﬁndings were correlated and the
ﬁnal diagnosis was membranous nephropathy secondary
to Kimura disease. The plan of management was intra-
venous cyclophosphamide, high dose steroids (60mg/day)
for 2 months, then gradual tapering, mycophenolate mof-
itel (2grams/day), and histamine −1, Chlorpheneramine
12mg; ranitidine 150mg BD receptor blockers. The patient
responded well to the previous anagement with complete
disappearance of skin lesions and normalization of kidney
function and disappearance of proteinuria (protein in urine
less than 200mg perday). Currently, the patient is on only a
small dose of prednisone (7.5mg/day).
3. Discussion
Kimuradisease(KD)isararechronicinﬂammatorydisorder
with angiolymphatic proliferation, usually aﬀecting young
men of Asian race and coexisting renal disease is common,
with an incidence ranging from 10% to 60% [1, 6].
Still it is of unknown etiology; a number of theories
have suggested impairment or interference with immune
regulation, atopic reaction to a persistent antigenic stimulusInternational Journal of Nephrology 3
by arthropod bites, virus [4], and neoplasm. The most
interesting one is that Candida acts as a source of persistent
antigenemia even subclinical [4].
Our case developed nephrotic syndrome with renal
dysfunction after 18 months of onset of Kimura disease.
Renal biopsy showed early membranous GN, in addition to
eosinophilic interstitial inﬁltrates.
The patient was responsive to steroids, with disappear-
ance of proteinuria 7 months after initiation of treatment.
This was matched with what reported by the US Armed
Forces Institute of Pathology [4] in most of the 20 other
cases reported as the onset of nephrotic syndrome occurred
after subcutaneous masses. Renal biopsy in 13 cases showed
mesangial proliferative glomerulonephritis in 9, minimal
change disease in 3, and membrane nephropathy in 2 cases.
Serum creatinine levels were elevated only in 5 patients.
In our patient skin biopsy showed angiolymphoid
hyperplasia with eosinophils which was matched with other
reports of Kimura disease [8].
KD is often associated with autoimmune diseases such
as ulcerative colitis and more frequently, unlike our case,
bronchial asthma [6], typically responding to steroids [9]. In
our case, we failed to diagnose the etiology after exclusion of
autoimmune disease.
Coexisting renal disease is common, with an incidence
ranging from 10% to 60% [7], while 10% to 12% of patients
may suﬀer from nephrotic syndrome [6]c h a r a c t e r i z e db y
clinically relevant proteinuria in 12% to 16% of cases [7].
Renal impairment is probably due to immunocomplex-




sis, cylindroma, dermatoﬁbrosarcoma protuberans, Kaposi’s
sarcoma, pyogenic granuloma, and other infectious lymph
node enlargements for example, toxoplasmosis.
Ultrasound, CT, and magnetic resonance imaging (MRI)
might be diagnostic and can help staging the extent and
progression of the disease as well as the lymph node
involvement.
Because of the rarity of KD in Western countries, both
cliniciansandradiologistsarerelativelyunfamiliarwithsome
pathognomonic ﬁndings of this disease, thus leading to
unnecessary diagnostic tests and investigations [7].
The diagnostic challenge of KD is generally solved by
histological study: although there is no speciﬁc diagnostic
feature of Kimura disease, ﬁne-needle aspiration cytology
is helpful in some cases, and deﬁnitive diagnosis can be
obtained by histological examination of the excised lesion
[4]. These ﬁndings were quite evident in all biopsies
taken from our patient (skin and renal) which showed
pronounced eosinophilic inﬁltrates, angiolymphoid hyper-
plasia eosinophilic renal interstitial inﬁltrates, and early
membranous nephropathy, respectively [10].
Treatment for Kimura disease includes surgical resection
and regional or systemic steroid therapy. Cytotoxic therapy
and radiation have also been utilized. The disease has an
excellent prognosis, although it may recur locally [11]. Sun
et al. [12], reported that Imatinib—previously to be useful
for treatment of hypereosinophilic syndrome and may work
by selectively blocking protein-tyrosine kinases—might be
an eﬀective drug for the treatment of the disease.
Our patient was subjected to nonradical surgical excision
of the temporal skin lesion without recurrence especially
after medical treatment. Treatment of KD is still controver-
sial: surgical excision of nodules is the ﬁrst-line treatment,
with recurrence rate up to 25%; in any case, because of
the lack of malignant transformation, radical or demolitive
surgery should be avoided [4].
Systemically administered steroids show good eﬀects on
disease progression. Due to its eﬀects on Th2 lymphocytes,
cyclosporine has been described as a possible therapy for KD
[13].
We tried single-pulse intravenous cyclophosphamide,
honestly before correlating the skin and renal biopsies,
then the patient was maintained on mycophenolate mofetil
(MMF) and high dose systemic steroid with satisfactory
response. This was not in agreement with that reported by
wang et al. [2] that Kimura disease-associated nephrotic
syndrome patients are sensitive to prednisone therapy but
are likely to relapse and that in patients with recurrent
nephrotic syndrome, renal insuﬃciency is not uncommon.
This diﬀerence could be explained by genetic factors and
diﬀerent immunosuppressive protocol used in management.
This report is a singular manifestation of KD: our
patient presented with atypical KD with renal aﬀection that
responded well to our immunosuppressive regimen without
relapse.
4. Conclusion
Kimura disease can present atypically in a middle-aged
Caucasian man with secondary steroid-responsive nephrotic
syndrome. Steroid, endoxan, and MMF can be used safely
and successfully in such situation. The diagnosis of KD can
be diﬃcult and misleading, and patients with this disease are
often evaluated using avoidable procedures by just not being
aware of KD.
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